文献速递分子诊断质量管理与危急值

将标准临床化学生物验证应用于微滴数字PCR定量液体活检

Applying Standard Clinical Chemistry Assay Validation to Droplet Digital PCR Quantitative Liquid Biopsy Testing.
PubMed 文献 · Clin Chem · 2018-09-20

本研究依据CLIA和CLSI指南,对KRAS、EGFR和BRAF定量ddPCR检测进行验证,评估了空白限、检测限、定量限、精密度、线性、准确度等指标。结果显示标准临床化学生物验证方案适用于ddPCR,有助于不同检测方法的性能比较及监测中最小显著变化阈值的建立。

要点

  • ddPCR检测的空白限为4个突变拷贝,检测限12-22拷贝,定量限35-64拷贝。
  • 动态范围上限为30000拷贝,稀释线性良好,加标回收准确。
  • 标准临床化学验证方案可用于ddPCR,支持方法间性能比较。

核心结论

  • 标准临床化学生物验证方案可应用于定量ddPCR检测,有助于不同检测方法的性能比较及监测中最小显著变化阈值的建立。

研究设计与样本

  • 依据CLIA实验室自建检测法规和CLSI指南,验证KRAS、EGFR和BRAF定量ddPCR检测,评估空白限、检测限、定量限、精密度、线性、准确度等指标。

主要发现

  • 空白限为4个突变拷贝,检测限为12至22拷贝,定量限为35至64拷贝。
  • 动态范围上限为30000拷贝,稀释至定量限仍线性,加标回收准确。
  • 与NGS和另一种ddPCR平台方法比较完全定性一致,定量一致性好,斜率0.73至0.97,R²为0.83至0.99。
  • 未发现明显干扰,健康个体血浆野生型拷贝数为462至6169/mL。

关键数值与推荐

  • 空白限为4个突变拷贝。
  • 检测限为12至22拷贝。
  • 定量限为35至64拷贝。
  • 动态范围上限为30000拷贝。
  • 方法比较斜率0.73至0.97,R²为0.83至0.99。

临床怎么用

  • 采用标准临床化学验证方案评估ddPCR检测性能,支持方法间比较和监测中最小显著变化阈值的建立。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Droplet digital PCR (ddPCR) is an emerging technology for quantitative cell-free DNA oncology applications. However, assay performance criteria must be established in a standardized manner to harness this potential. We reasoned that standard protocols used in clinical chemistry assay validation should be able to fill this need. METHODS: We validated KRAS, EGFR, and BRAF quantitative ddPCR assays based on the Clinical Laboratory Improvement Act regulations for laboratory-developed tests in clinical chemistry and the matching Clinical and Laboratory Standards Institute guidelines. This included evaluation of limit of the blank (LOB), limit of detection (LOD), limit of quantification (LOQ), intraassay and interassay imprecision, analytical range, dilution linearity, accuracy (including comparison with orthogonal platforms), reference range study, interference, and stability studies. RESULTS: For the ddPCR assays, the LOB was 4 mutant copies, LODs were 12 to 22 copies, and LOQs were 35 to 64 copies. The upper limit of the dynamic range was 30000 copies, and dilutions were linear down to the LOQs with good accuracy of spike recovery of Horizon reference material. Method comparisons with next-generation sequencing and an alternative ddPCR platform showed complete qualitative agreement and quantitative concordance, with slopes of 0.73 to 0.97 and R 2s of 0.83 to 0.99. No substantial interferences were discovered. Wild-type copy numbers in plasma ranged from 462 to 6169/mL in healthy individuals. CONCLUSIONS: Standard clinical chemistry assay validation protocols can be applied to quantitative ddPCR assays. This should facilitate comparison of the performance of different assays and allow establishment of minimal significant change thresholds in monitoring applications.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Milosevic D, Mills JR, Campion MB, et al. Applying Standard Clinical Chemistry Assay Validation to Droplet Digital PCR Quantitative Liquid Biopsy Testing. Clin Chem. 2018. PMID: 30237149. doi:10.1373/clinchem.2018.291278

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。